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Abstract
Purpose: In humans, activation-induced cytidine deaminase (AID) expression results due to inflammation and this
deaminase activity is also involved in carcinogenesis. The aim of this study is to investigate the correlation between AID
expression and the clinical classification of oral cancer tissues.
Experimental Design: The current study investigated the correlation between AID expression and the clinical classification
of oral cancer tissues from 27 patients who underwent surgical resection using immunohistochemistry. Specific AID
expression and its induction by cytokine stimulation were investigated in cultured HSC oral cancer cell lines by reverse
transcriptase PCR.
Results: AID expression was detected in 10 of 27 specimens (37.0%). AID expression was more frequently detected in early-
stage cancer, especially in early stage T, than in late-stage cancer (T1/T2 vs. T3/4; P = 0.0493, N0 vs. N1/2/3; P = 0.0793). HSC-
2, a nonmetastatic oral cancer cell line, abundantly expressed endogenous AID, whereas no such expression was observed
in HSC-3, a metastatic oral cancer cell line. Moreover, AID expression was substantially induced in HSC-2 cells by stimulation
of an inflammation-related cytokine, TNF-a.
Conclusions: Aberrant AID expression in the oral epithelium would contribute to the initiation of oral squamous cell
carcinoma. Avoiding persistent AID inducible condition such as frequent cleaning of oral cavity would play an important
role for the prevention of developing oral cancer.
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Introduction
Head and neck cancer is the sixth most common malignancy
worldwide [1]. Most cancers of the head and neck are squamous
cell carcinomas, and most of these are oral squamous cell
carcinomas. In addition to the classical risk factors for oral cancer,
namely alcohol and tobacco, infections such as those from human
papillomavirus are considered to be associated with the de-
velopment of oral malignancies [2,3]. Worldwide, 25% oral
cancers are attributable to tobacco use (smoking and/or chewing),
7%–19% to alcohol consumption, 10%–15% to micronutrient
deficiency, and more than 50% to betel quid chewing in areas of
high chewing prevalence [4]. Correlations have been reported
between metastatic tumor recurrence and expression of metastasis-
promoting factors such as matrix metalloproteinases (MMPs),
tissue inhibitors of MMP-2 (TIMP-2), Ets-1, and autocrine motility
factor in patients with tongue squamous cell carcinoma [5–7]. We
have also reported the correlation between TIMP-2 expression
and MMP-2 expression and have predicted a poor prognosis in
patients with squamous cell carcinoma of the tongue [7].
However, the mechanisms by which oral squamous cells undergo
genetic changes, which subsequently lead to their malignant
transformation remain unknown.
Activation-induced cytidine deaminase (AID) is a member of the
cytidine deaminase family [8] and is closely related to apolipo-
protein B RNA-editing cytidine deaminase 1, which converts
cytosine to uracil in RNA [9]. AID is essential for immunoglobulin
gene diversification, which is caused by somatic hypermutation
and class switch recombination [10]. AID expression is induced by
stimulation of proinflammatory cytokines such as TNF-a in
hepatocytes, cholangiocytes, and gastric cells [8,9,11]. Further-
more, AID introduces mutations into nonimmunoglobulin genes
[12,13]. Cascalho reported that AID could act as a DNA mutator
that contributes to tumorigenesis through its cytidine deaminase
activity [14]. Indeed, constitutive AID expression in transgenic
mice induces tumor development in various tissues, including
epithelial tissues, in association with high mutation frequencies
[12].
The oral cavity is exposed to many stimulants such as food,
microbes, and chemical agents. These conditions are fit for
triggering an inflammatory cascade. Previous reports led us to
hypothesize that AID expression is ectopically induced by
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proinflammatory cytokines in oral tissues, and that such aberrant
AID expression may be involved in the development of oral
cancer. In the current study, immunohistochemical examination
revealed AID expression in early-stage oral squamous cell
carcinoma. In addition, TNF-a, a proinflammatory cytokine,
upregulated AID expression in the HSC-2 oral cancer cell line.
Materials and Methods
Case Selection
Twenty-seven cases of oral cancer treated between 1999 and
2006 at the division of Otolaryngology, Head and Neck Surgery,
Kanazawa University Hospital, Japan were identified. The
clinicopathological stage of these cases were categorized on the
basis of the tumor/nodes/metastasis (TNM) classification of
malignant tumors of the Union Internationale Contre le Cancer
[15] (Table 1). Surgical resection was the initial treatment in all
cases included in this study.
Ethics Statement
The study was approved by the Ethics Committee of Kanazawa
University, and informed consent was obtained from each patient
before enrollment.
Cells and Cell Cultures
HSC-2 and HSC-3 cells were extracted from metastatic lymph
node tumors originating in patients with oral squamous cell
carcinoma [16]. Cells were cultured in Dulbecco’s Modified Eagle
Medium (GIBCO-BRL, Grand Island, NY) supplemented with
10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 mg/
mL streptomycin in culture flasks in humidified 5% CO2 at 37uC.
BL2 cells (a human germinal center B cell line) were cultured in
RPMI1640 medium supplemented with 10% FBS, 100 U/mL
penicillin, 100 mg/mL streptomycin, and 0.004% 2-mercap-
toethanol in culture flasks in humidified 5% CO2 at 37uC.
Immunostaining of AID
For immunohistochemical analysis, formalin-fixed, paraffin-
embedded blocks were obtained from primary tumors. Consecu-
tive 4-mm sections were subsequently cut from each tumor block.
Monoclonal antibodies against AID included EK2 5G9 (Cell
Signaling Technology Inc., Boston, MA, USA) and mAID2
(eBioscience Inc., San Diego, CA, USA). Immunohistochemical
staining was performed with the Vectastain Elite ABC kit (Vector
Laboratories Inc., Burlingame, CA, USA). The sections were
color-developed with substrate/chromogen diaminobenzidine
(DAKO) and subsequently counterstained with methyl green.
Evaluation of AID Immunohistochemical Staining
The stained sections were independently examined by two
authors (Y. N. and S. K.). In each case, two separate arbitrarily
selected microscopic fields (2006) containing more than 200
tumor cells were evaluated. After counting the immunoreactive
cells and the total number of tumor cells, the average percentages
of immunoreactive cells were calculated without knowledge of the
clinical data, and specimens were classified into two groups:
positive ($5%) and negative (,5%).
Dual Fluorescent Immunostaining
All oral squamous cell carcinoma specimens that expressed AID
on single immunostaining were used for dual fluorescent
immunostaining. Dual fluorescent staining for AID (EK2 5G9)
and cytokeratins (CK) (AE1/AE3; DAKO) was performed to
assess the location of cancer cells expressing AID in each
specimen. Deparaffinized sections were microwaved in a citrate
buffer (pH 6.0) for 20 min and incubated in Protein Block Serum-
Free (DAKO Cytomation) for 20 min. The specimens were
incubated overnight at 4uC with primary antibodies to AID and
CK. The reaction product was visualized with fluorescent goat
anti-mouse Alexa Fluor 488 and anti-rabbit Alexa Fluor 594 IgG
secondary antibodies (1:500; Molecular Probes Inc., Eugene, OR).
Specimens were counterstained with 49,6-diamidino-2-phenylin-
dole (Molecular Probes) and observed under a microscope. No
positive staining was observed when the primary antibodies were
omitted or replaced with normal serum in the negative controls
during the staining procedures.
Reverse Transcription-polymerase Chain Reaction (RT-
PCR) and DNA Sequencing
To analyze AID expression in oral squamous cancer cell lines,
expression of AID transcripts was investigated in HSC-2, HSC-3,
and BL2 cells by RT-PCR using MyCyclerTM (Bio-Rad). Total
RNA was isolated using an RNeasy Mini Kit (QIAGEN, Hilden,
Germany) and reverse transcribed with an oligo-dT using
SuperScript III (Invitrogen). The following primers sets were used
for amplification of AID and b-actin: AID, 59-
AAATGTCCGCTGGGCTAAGG-39 (forward) and 59-GGAG-
GAAGAGCAATTCCACGT-39 (reverse); b-actin, 59-GACCT-
GACTGACTACCTCATGAAGA-39 (forward) and 59-
GGGGCCGGACTCGTCATACTCCTGC-39 (reverse). PCR
reactions were performed using the following conditions, AID:
35 cycles at 94uC for 15 sec, 54uC for 20 sec, and 70uC for 20 sec;
b-actin: 30 cycles at 94uC for 15 sec, 54uC for 20 sec, and 70uC
for 20 sec. The products were subcloned into a pGEM-T Easy
vector (Promega, Madison, WI), and the resulting plasmids were
sequenced using a 3130 Genetic Analyzer (Applied Biosystems) to
verify DNA amplification.
Quantitative Real-time RT-PCR
The quantification of gene expression was performed by
quantitative real-time RT-PCR using the Mx3000P (Stratagene)
QPCR system and THUNDERBIRD SYBR qPCR Mix
(Toyobo). The following primer sets were used for the amplifica-
tion of human AID: 59-AAATGTCCGCTGGGCTAAGG-39
(forward) and 59-GGAGGAAGAGCAATTCCACGT-39 (re-
Table 1. Patients characteristic.
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verse). Standard curves for AID were generated for every target
using a 100-fold serial dilution series of 5 independent transcripts
derived from BL2 cells that showed a high level of endogenous
AID expression. The following conditions were used: 40 cycles at
94uC for 15 sec, 54uC for 20 sec, and 72uC for 30 sec.
Figure 1. Aberrant expression of AID protein in oral tissues and oral squamous cell carcinoma tissue. Representative images of
immunostaining for endogenous AID are shown. To demonstrate physiological expression of AID protein, normal lingual epithelium (A) and
a germinal center in normal neck lymphoid tissue (B) were reacted with an anti-AID antibody. The germinal center containing AID-expressing B
lymphocytes shows clear positive staining (brown). However, no AID expression was observed in normal lingual epithelium. Representative
moderate-to-strong AID immunostaining is shown in the tumor tissues of oral squamous cell carcinoma classified as T2 (C, D) and neck metastatic
tissues classified as N1 (F) and N2 (E). (6200).
doi:10.1371/journal.pone.0062066.g001
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To assess the quantity of isolated RNA and the efficacy of
cDNA synthesis, target cDNAs were normalized to the endoge-
nous mRNA levels of the housekeeping gene hypoxanthine
phosphoribosyltransferase (HPRT). The following primer sets
were used for the amplification of HPRT cDNA: 59-
GCCCTGGCGTCGTGATTAGT-39 (forward) and 59-CGAG-
CAAGACGTTCAGTCCTGTC-39 (reverse). PCR conditions
were the same as those used for AID. PCR amplifications were
performed at least 3 times for each sample.
Statistical Analysis
Results were analyzed using the Mann–Whitney U test, and
differences of P,0.05 were considered statistically significant.
Statistical analyses were performed using the SPSS 19.0 software
package.
Results
Immunostaining of AID in Oral Cancer Tissues
To clarify AID expression and localization in human oral
cancer cells under physiological and pathological conditions,
immunohistochemistry was performed. We confirmed the speci-
ficity and sensitivity of the used anti-AID antibodies by western
blotting using control human cell lines (Fig. S1). BL2 is a human
germinal center B lymphocyte line that expresses abundant AID
protein, and Faili et al generated AID deficient BL2 cells by gene
targeting approach [17]. Results of western blotting demonstrated
detection of AID protein only from AID wild type BL2 cells but
not from AID deficient BL2 nor Huh7 cells, a human hepatocyte
cell line. Moreover the specificity of the antibody was further
supported by control staining of the normal lingual epithelium
(Fig. 1A and S2A) and germinal centers of human neck lymph
nodes (Fig. 1B and S2B). As reported previously, the germinal
centers contained AID-expressing B cells, whereas normal lingual
epithelium tissue does not contain AID-positive cells [18]. This
indicates that the immunostaining protocol used in our study
specifically detected physiological expression of the AID protein.
Under this protocol, abundant AID expression was detected
mainly in oral cancer tumor cells (Fig. 1C and D) and neck
metastatic tissues (Fig. 1E and F).
Double Staining of CK and AID in Oral Cancer Tissues
Germinal center B lymphocytes expressed high levels of AID
(Fig. 1B) [8,18]. Activated B lymphocytes may infiltrate tumor
regions. Therefore, to examine whether tumor cells expressing the
AID protein are really epithelial cells, double staining of CK and
AID was performed (Fig. 2). CK is an epithelial cell marker that is
not expressed in B lymphocytes [19]. Figure 2 demonstrates that
Figure 2. Dual-fluorescent immunostaining of cytokeratins (CK) (A), AID (B), and DAPI (C) in oral cancer tissues. CK and AID were
coexpressed in oral cancer tissues (arrows in D). Original magnifications:6200.
doi:10.1371/journal.pone.0062066.g002
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cells expressing CK also expressed AID in oral cancer specimens.
Strong cytoplasmic staining (inset) in the merged figure supported
localization of AID, as previously reported [20,21].
AID Overexpression in Early-stage Oncogenesis of Oral
Squamous Cell Carcinoma
Twenty-seven specimens of oral cancers surgically resected at
initial treatment were used for immunostaining. The correlation
between AID expression and T and N categories according to the
TNM classification in the specimens was examined. T describes
the size of the tumor and its invasion into nearby tissue. N
describes regional lymph node involvement. AID immunoreactiv-
ity was detected in 10 of the 27 resected specimens (37.0%). The
number of AID-positive cases in T1 and T2 cases was significantly
higher than that in T3 and T4 specimens (P= 0.0493). No
statistical difference was detected in the frequency of positivity for
AID expression in N0 specimens compared with that in N2 and
N3 specimens (P = 0.0793) (Fig. 3).
AID Expression in Oral Cancer Cell Lines
To investigate the relationship between N classification and
AID expression further, HSC-2 and HSC-3 cell lines were used as
nonmetastatic and metastatic models, respectively [16]. RT-PCR
detected endogenous AID expression in HSC-2 cells; however,
AID expression was less in HSC-3 cells (Fig. 4). This result suggests
that AID expression is associated with nonmetastatic oral cancer
cells.
Endogenous AID Expression is Induced in Response to
TNF-a in Oral Cancer Cell Lines
Previous studies reported that AID expression is induced by
cytokines such as TNF-a in B lymphocytes and epithelial cells
[11,22,23]. Therefore, the expression of endogeneous AID
induced by TNF-a in HSC-2 cells was examined. Quantitative
real-time RT-PCR revealed that AID expression was upregulated
approximately 4-fold at 24 h after treatment with TNF-a (Fig. 5).
However, western blotting of AID failed to detect AID protein in
the TNF-a stimulated HSC-2 cells, suggesting AID protein
expression level is much lower than that of BL2 cells (data not
shown). This result suggests that AID expression is upregulated in
inflammatory conditions and is mediated by inflammatory
cytokines such as TNF-a, though the level of protein expression
is unknown. Detection of AID transcripts by RT-PCR (Fig. 4) and
RT-qPCR (Fig. 5) was verified by DNA sequencing of PCR
products.
Discussion
This is the first study that demonstrates AID expression in oral
squamous cell carcinoma. AID was originally isolated from murine
B lymphoma cells, and it is specifically expressed in germinal
center B cells [8]. Further, incidences of AID expression have
recently been reported in non-B cells including human hepato-
cytes, biliary cells, gastric epithelial cells, and colonic epithelial
cells [11,22,24,25]. Because accumulating data strongly suggests
that AID is a genomic mutator, this study investigated the
Figure 3. AID is expressed in tissues from patients with early-
stage oral cancer. AID immunoreactivity was detected in 10 of 27
specimens (37.0%). The frequency of positivity for AID expression in T1
and T2 cancer was significantly higher than that in T3 and T4 cancer (A).
The frequency of positivity for AID expression in N0 cancer tended to be
higher than that in N2 and N3 cancer (B). Closed and open boxes
represent expression and lack of expression of AID protein, respectively.
doi:10.1371/journal.pone.0062066.g003
Figure 4. RT-PCR for the expression of AID in oral cancer cells.
RT-PCR was performed using oligonucleotide primer sets specific for
human AID and b-actin. A germinal center B cell line (BL-2) was used as
a positive control and H2O was used as negative control.
doi:10.1371/journal.pone.0062066.g004
Figure 5. AID mRNA expression is upregulated in HSC-2 and
HSC-3 cells in response to TNF-a expression. Total RNA was
extracted from HSC-2 and HSC-3 cells after 24 h and 48 h of treatment
with TNF-a (100 ng/ml). AID transcripts were measured by quantitative
real-time PCR. After normalization by expression of the housekeeping
gene human hypoxanthine phosphoribosyltransferase (HPRT), fold
induction of AID expression treated with TNF-a was demonstrated.
Expression of AID levels at 0 h was defined as one fold induction.
*P,0.05.
doi:10.1371/journal.pone.0062066.g005
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relationship between AID expression and oral cancer. The results
demonstrated that AID was overexpressed in human oral cancer
cells in vitro and in vivo.
The in vitro data in HSC-2 cell lines (Fig. 5) demonstrated that
AID was induced by TNF-a. TNF-a is upregulated in oral cancer
tissues, as reflected in previous analyses of several inflammatory
salivary cytokines in the saliva of oral cancer patients [26,27]. In
addition, TNF-a is considered to be one of the key mediators of
oral carcinogenesis. Therefore, it is reasonable to speculate that
AID expression may be induced by certain inflammatory
mediators such as TNF-a in oral squamous cells. The molecular
mechanism underlying AID upregulation in oral tissues is unclear.
A potential nuclear factor kappa-light chain enhancer site was
identified approximately 1.4 kb upstream of the transcription start
site of the AID gene [28–30]. This site was suggested to be
responsible for the cell’s response to viral infection and TNF-
a signaling [30,31]. Furthermore, AID can be expressed in non-B
cells under certain conditions, such as in response to infection,
inflammatory cytokines, and hormones.
In this study, the immunohistochemical data obtained from
analysis of clinical oral cancer tissues implied that AID expression
correlated with the early stages of cancer development. In our
in vitro study, AID was expressed in HSC-2 oral cancer cells with
no metastases. The results of this study suggest that AID is
important in initiation of oral carcinogenesis. AID expression has
been demonstrated in Barrett’s epithelial cells and the gastric
mucosa of patients with gastric atrophy and intestinal metaplasia,
which are regarded as a precancerous condition [24,32]. Infection
with cag pathogenicity island-positive Helicobacter pylori, which has
been implicated in the pathogenesis of gastric cancer, ectopically
induces high AID expression in human gastric cells, suggesting
that AID plays an initial role in the carcinogenesis of gastric
cancer. Therefore, AID expression in oral premalignant lesions
such as leukoplakia is a topic for future study.
This study demonstrated that AID expression in oral squamous
cells is induced in response to inflammatory cytokine stimulation
and plays an important role in early stages of oral carcinogenesis.
These findings may suggest a common mechanism for the
regulation of AID gene expression under inflammatory conditions.
In conclusion, the results of this study demonstrated a correla-
tion between aberrant AID expression and early-stage oral cancer.
These findings suggest that aberrant AID expression is induced by
persistent inflammation and may contribute to the initiation of
oral squamous cell carcinoma.
Supporting Information
Figure S1 Specific detection of AID protein by AID
antibodies. Western blot was performed to show specific
detection of endogenous AID protein by anti-AID antibodies
used in this study. Whole cell lysates from AID deficient (AID KO)
BL2, AID wild type (AID Wt) BL2, and control (control) cells were
loaded as indicated. Different loading (0.18 and 0.66106 per lane)
was tested for BL2 cells. Signals representing AID protein were
only detected from AID wild type BL2 cells but not from AID
deficient or control cells. Top and middle; anti-AID monoclonal
anitbodies (MAID2 and EK2). CBB; Comassie brilliant blue.
(TIF)
Figure S2 Control staining with secondary antibodies
alone. The secondary antibody alone did not show any positive
staining in normal lingual epithelium (A) and germinal centers of
human neck lymph nodes (B), excluding pseudo-positive signals
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